Lung Kee (Bermuda) Holdings Limited (0255) Stock Price & Analysis

2 Followers

0255 Stock Chart & Stats

HK$1.36HK$0.01(0.37%)

At close: Nov 11 4:00 PM GMT+8

Day’s Range: HKD 1.30 - HKD 1.37
52-Week Range: HKD 1.30 - HKD 1.98
Previous Close: HKD 1.36
Volume: N/A
Average Volume (3M): 12.60K
Market Cap: HKD 859.27M
Enterprise Value: HKD 253.26M
Total Cash (Recent Filing): HKD 649.71M
Total Debt (Recent Filing): HKD 2.79M
Price to Earnings (P/E): ―
Beta: 0.29
Next Earnings: Mar 19, 2027 (Est.)
EPS Estimate: N/A
Last Dividend Ex-Date: Sep 04, 2026
Dividend Yield: 14.71%

Bulls Say, Bears Say

Bulls Say

Very Low Leverage

A near-zero debt burden gives Lung Kee substantial financial flexibility during the earnings downturn. Low leverage limits solvency and refinancing pressure, preserves capacity to fund operations internally, and leaves the company better positioned to withstand prolonged weakness.

Resilient Cash Generation

Positive operating cash flow despite reported losses indicates that the business continues to convert activity into cash. Recent positive free cash flow supports ongoing operations and reduces reliance on borrowing, although the recent moderation warrants monitoring.

Positive EBITDA Base

Positive EBITDA suggests the core business still generates earnings before depreciation and amortization, despite negative operating profit. The smaller losses versus 2023 provide evidence of some underlying resilience and could support recovery if revenue stabilizes.

Bears Say

Persistent Losses

Three consecutive years of net losses and negative operating profit show that current revenue and cost economics are not producing sustainable bottom-line earnings. Continued losses can erode equity returns and constrain the company’s ability to reinvest from internally generated profits.

Revenue Contraction

The renewed 2025 revenue decline indicates that demand has not yet established a durable growth path. A shrinking top line makes fixed-cost absorption more difficult, increases pressure on margins, and may delay a return to positive operating profitability.

Uneven Free Cash Flow

Although recent free cash flow is positive, the history of negative results and the 2025 decline demonstrate that cash generation is not consistently dependable. This uneven record could limit flexibility for investment, distributions, or navigating further operating weakness.

Lung Kee (Bermuda) Holdings Limited News

Lung Kee Clarifies Scope of Share Options in 2025 Annual Report

Lung Kee (Bermuda) Holdings Limited ( ($HK:0255) ) just unveiled an update. Lung Kee Group Holdings Limited, incorporated in Bermuda and listed on the Hong Kong Stock Exchange, operates in

2M ago0255

Lung Kee Announces Interim Cash Dividend for First Half of 2026

Lung Kee (Bermuda) Holdings Limited ( ($HK:0255) ) has shared an announcement. Lung Kee Group Holdings Limited has declared an interim ordinary cash dividend of HKD 0.08 per share for

2M ago0255

Lung Kee Group Swings to Larger Interim Loss Amid Revenue Decline

Lung Kee (Bermuda) Holdings Limited ( ($HK:0255) ) has issued an announcement. Lung Kee Group reported unaudited interim revenue of HK$568.3 million for the six months ended 30 June 2026,

2M ago0255

Lung Kee Group Sets August Board Meeting to Approve Interim Results and Consider Dividend

Lung Kee (Bermuda) Holdings Limited ( ($HK:0255) ) has issued an update. Lung Kee Group Holdings Limited has scheduled a board meeting for 21 August 2026 in Hong Kong to

3M ago0255

Lung Kee Group Updates Bermuda Registered Office Address

Lung Kee (Bermuda) Holdings Limited ( ($HK:0255) ) has provided an update. Lung Kee Group Holdings Limited has announced a change to the address of its registered office in Bermuda,

3M ago0255

Lung Kee Shareholders Approve All AGM Resolutions, Endorse Dividend and Capital Mandates

Lung Kee (Bermuda) Holdings Limited ( ($HK:0255) ) just unveiled an announcement. Lung Kee Group Holdings Limited reported that shareholders approved all resolutions at its 18 May 2026 annual general

5M ago0255

Lung Kee Calls 2026 AGM, Seeks Share Issue Mandate and Board Re-elections

Lung Kee (Bermuda) Holdings Limited ( ($HK:0255) ) just unveiled an announcement. Lung Kee Group Holdings Limited has called its annual general meeting for 18 May 2026 in Hong Kong,

7M ago0255

Lung Kee Group Declares Final HKD 0.12 Dividend for 2025

An announcement from Lung Kee (Bermuda) Holdings Limited ( ($HK:0255) ) is now available. Lung Kee Group Holdings Limited has declared a final ordinary cash dividend of HKD 0.12 per

7M ago0255

Lung Kee widens annual loss as revenue falls but posts positive comprehensive income

Lung Kee (Bermuda) Holdings Limited ( ($HK:0255) ) has shared an announcement. Lung Kee Group Holdings Limited reported a decline in full-year 2025 revenue to HK$1.32 billion from HK$1.55 billion

7M ago0255

Lung Kee Group Sets March Board Meeting to Approve 2025 Results and Final Dividend Plan

An announcement from Lung Kee (Bermuda) Holdings Limited ( ($HK:0255) ) is now available. Lung Kee Group Holdings Limited has scheduled a board meeting for 20 March 2026 in Hong

8M ago0255

0255 FAQ

What was Lung Kee (Bermuda) Holdings Limited’s price range in the past 12 months?

Lung Kee (Bermuda) Holdings Limited lowest stock price was HK$1.30 and its highest was HK$1.98 in the past 12 months.

What is Lung Kee (Bermuda) Holdings Limited’s market cap?

Lung Kee (Bermuda) Holdings Limited’s market cap is HK$859.27M.

When is Lung Kee (Bermuda) Holdings Limited’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Lung Kee (Bermuda) Holdings Limited’s earnings last quarter?

Lung Kee (Bermuda) Holdings Limited released its earnings results on Aug 21, 2026. The company reported -HK$0.016 earnings per share for the quarter.

Is Lung Kee (Bermuda) Holdings Limited overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Lung Kee (Bermuda) Holdings Limited pay dividends?

Lung Kee (Bermuda) Holdings Limited pays an annual dividend of HK$0.08 which represents an annual dividend yield of 14.71%. See more information on Lung Kee (Bermuda) Holdings Limited dividends here

What is Lung Kee (Bermuda) Holdings Limited’s EPS estimate?

Lung Kee (Bermuda) Holdings Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Lung Kee (Bermuda) Holdings Limited have?

Lung Kee (Bermuda) Holdings Limited has 634,147,300 shares outstanding.

What happened to Lung Kee (Bermuda) Holdings Limited’s price movement after its last earnings report?

Lung Kee (Bermuda) Holdings Limited reported an EPS of -HK$0.016 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Lung Kee (Bermuda) Holdings Limited?

Currently, no hedge funds are holding shares in HK:0255

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Lung Kee (Bermuda) Holdings Limited Stock Smart Score

Neutral

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description